Rx Price Debate Could Kill Senate FDA-Reform Legislation

Senate health committee ranking Democrat Patty Murray (WA) said she is considering measures to deal with drug prices as part of the panel's upcoming medical product innovation bill, and Republican lobbyist and congressional aide sources say they doubt key Democrats will vote for a pro-drug industry innovation bill unless drug-price measures are included, as the leading two Democratic presidential candidates are criticizing pharmaceutical price increases. “We’re working on it,” Murray said in response to a question about whether the upcoming...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.